• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agency of Health Technology Assessment of Uruguay
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canada’s Drug Agency (CDA-AMC)
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Healthcare Quality Institute
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Regione Emilia Romagna
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [479 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2019 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Olaparib (Lynparza®) as first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer
2019 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Robot-assisted surgery in thoracic and visceral indications
2019 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Single/two-step scaffold-based cartilage repair in the knee and ankle joint
2019 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Enzalutamide (Xtandi®) in addition to standard first-line therapy in men with metastatic hormone-sensitive prostate cancer (mHSPC)
2019 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Sponsoring of Patient Initiatives in Austria 2018. Update of the Systematic Analyses 2014, 2015 and 2016
2019 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Pembrolizumab (Keytruda®) as first-line therapy for PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (NSCLC)
2019 Institut national d'excellence en sante et en services sociaux (INESSS) [Guidelines and standards: autonomy in intellectually disabled young people aged 6 to 21 years]
2019 Health Quality Ontario (HQO) Intermittent Catheters for Chronic Urinary Retention: A Health Technology Assessment
2019 Institut national d'excellence en sante et en services sociaux (INESSS) [Guidelines and standards: post-tick bite antibiotic prophylaxis to prevent Lyme disease, report in support of the knowledge transfer tools, the Québec’s national medical protocol and the collective prescription template]
2019 The Federal Joint Committee (G-BA) [Pharmaceutical Directive/Annex XII: Bedaquiline (assessment of an orphan drug after exceeding the turnover limit of €1 million)]
2019 Ontario Health Osseointegrated Prosthetic Implants for People With Lower-Limb Amputation: A Health Technology Assessment
2019 Health Sciences Institute in Aragon (IACS) Efficacy, effectiveness and safety of intraoperative radiotherapy in breast carcinoma
2019 Belgian Health Care Knowledge Centre (KCE) Proton beam therapy in adults
2019 Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale (CIUSSS) [Identification of psychosocial practices and interventions that support the adaptation and rehabilitation of adults with Prader-Willi Syndrome]
2019 NIHR Health Services and Delivery Research programme Improving care for women and girls who have undergone female genital mutilation/cutting: qualitative systematic reviews
2018 NIHR Health Technology Assessment programme Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation
2018 Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: regulation of private congregate living facilities for the elderly]
2018 Institut national d'excellence en sante et en services sociaux (INESSS) [Report: the use of EndoPredict and Prosigna for early invasive breast cancer]
2018 Institut national d'excellence en sante et en services sociaux (INESSS) [Report: cardiopulmonary resuscitation (CPR) in a context of community-based naloxone administration for opioid overdose]
2018 Norwegian Institute of Public Health (NIPH) 177Lutetium-based peptide receptor radionuclide therapy for treating neuroendocrine tumours: a health technology assessment
2018 Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: a profile of the practices adopted in Quebec to facilitate the transition to adulthood of young people who reside in an alternative living facility]
2018 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Lymphovenous anastomoses in patients with primary and secondary lymphoedema
2018 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Carbon ion beam radiotherapy (CIRT) for cancer treatment: a systematic review of effectiveness and safety for 12 oncologic indications
2018 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Enzalutamide (Xtandi®) in patients with nonmetastatic, castration-resistant prostate cancer (CRPC)
2018 Andalusian Health Technology Assessment Area (AETSA) Electrical stimulation of peripheral nerves for treating chronic refractory pain
2018 Andalusian Health Technology Assessment Area (AETSA) Quality criteria and good practices in organizations dedicated to the Health Technologies Assessment
2018 Health Quality Ontario (HQO) Continuous monitoring of glucose for Type 1 Diabetes: a health technology assessment
2018 Basque Office for Health Technology Assessment (OSTEBA) [Evaluation of the scientific evidence on nipple-areola complex micropigmentation, requirements for its proper implementation and costs]
2018 Basque Office for Health Technology Assessment (OSTEBA) [Effectiveness and safety of bone suppression technology for the detection of lung cancer and indications for its use]
2018 NIHR Health Technology Assessment programme Treatments for dry age-related macular degeneration and Stargardt disease: a systematic review
2018 Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal use guide: antibiotic prophylaxis during clean orthopedic surgery in children and adults]
2017 HAYES, Inc. Dorsal root ganglion stimulation for the treatment of complex regional pain syndrome
2017 NIHR Public Health Research (PHR) programme Evaluation of the impacts on health of the proposed UK industry levy on sugar sweetened beverages: developing a systems map and data platform, and collection of baseline and early impact data
2017 Institut national d'excellence en sante et en services sociaux (INESSS) [Report: organization of the continuum and provision of services to children aged 2 to 9 years with specific language impairment]
2017 Norwegian Institute of Public Health (NIPH) Sutureless aortic valve replacement for treatment of severe aortic stenosis: A single technology assessment of Perceval sutureless aortic valve
2017 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Prostate artery embolisation for benign prostatic hyperplasia
2017 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Ipilimumab (Yervoy®) in the adjuvant therapy for high-risk stage III cutaneous melanoma
2017 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Ceritinib (Zykadia®) as first-line therapy for patients with advanced ALK-positive non-small cell lung cancer
2017 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Electric stimulation therapy (EST) in patients with gastroesophageal reflux disease
2017 Agency for Healthcare Research and Quality (AHRQ) Supplemental project to assess the transparency of reporting for strategies to improve mental health care for children and adolescents
2017 NIHR Health Technology Assessment programme Cabozantinib for previously treated metastatic renal cell carcinoma [ID931]
2017 NIHR Health Technology Assessment programme The Asymptomatic Carotid Surgery Trial-2 (ACST-2): an ongoing randomised controlled trial comparing carotid endarterectomy with carotid artery stenting to prevent stroke
2017 HAYES, Inc. Laparoscopic electromechanical morcellation of uterine fibroids during myomectomy orhysterectomy
2017 HAYES, Inc. Surgical treatment for lymphedema: a review of reviews
2017 Technology Assessment Unit of the McGill University Health Centre (MUHC) Use of extracorporeal membrane oxygenation for cardiac life support in adult subjects
2017 HAYES, Inc. Subcutaneous implantable cardioverter defibrillator (S-ICD) for prevention of sudden cardiac death
2017 NIHR Health Technology Assessment programme Self-management toolkit and delivery strategy for end-of-life pain: the mixed-methods feasibility study
2017 Canary Health Service [Tools for early detection of disease-related malnutrition for adult population in the hospital setting]
2017 HAYES, Inc. Impella CP (Abiomed) for use in adult patients with cardiogenic shock
2017 Belgian Health Care Knowledge Centre (KCE) Bevacizumab in the treatment of ovarian cancer
2016 NIHR Horizon Scanning Centre (NIHR HSC) Afatinib (Giotrif) for advanced or metastatic, squamous non-small cell lung cancer progressing on or after platinum-based chemotherapy
2016 HAYES, Inc. Noninvasive electrical bone growth stimulators for acute, delayed union, and nonunion fractures
2016 The Federal Joint Committee (G-BA) [Pharmaceutical Directive/Annex XII: Ataluren (expiry of the deadline)]
2016 NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab (Opdivo) for stage IV or recurrent PD-L1 positive non-small cell lung cancer – first line
2016 NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab (Opdivo) for stage IV or recurrent non-small cell lung cancer – first line
2016 Adelaide Health Technology Assessment (AHTA) Transcranial magnetic resonance-guided focused ultrasound and deep brain stimulation for refractory depression
2016 NIHR Health Technology Assessment programme The Protease Inhibitor Monotherapy Versus Ongoing Triple Therapy (PIVOT) trial: a randomised controlled trial of a protease inhibitor monotherapy strategy for long-term management of human immunodeficiency virus infection
2016 NIHR Horizon Scanning Centre (NIHR HSC) Crizotinib (Xalkori) for advanced ROS1 positive non-small cell lung cancer – first line
2016 Canary Health Service [Extracorporeal membrane oxygenation (ECMO) in patients with advanced heart failure or cardiogenic shock]
2016 NIHR Health Technology Assessment programme BREATHER (PENTA 16) short-cycle therapy (SCT) (5 days on/2 days off) in young people with chronic human immunodeficiency virus infection: an open, randomised, parallel-group Phase II/III trial
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Pembrolizumab for the treatment of advanced melanoma
2016 NIHR Horizon Scanning Centre (NIHR HSC) Dabrafenib (Tafinlar) and trametinib (Mekinist) combination therapy for advanced BRAF mutated non-small cell lung cancer
2015 Canadian Agency for Drugs and Technologies in Health (CADTH) Transoral robotic surgery: a review of clinical and cost-effectiveness
2015 Institut national d'excellence en sante et en services sociaux (INESSS) [Efficacy of intraoperative radiation therapy]
2015 NIHR Health Services and Delivery Research programme Development, validation and evaluation of an instrument for active monitoring of men with clinically localised prostate cancer: systematic review, cohort studies and qualitative study
2015 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Percutaneous transluminal angioplasty (PTA) of peripheral arteries with drug-eluting balloon (DEB)]
2015 Institut national d'excellence en sante et en services sociaux (INESSS) [Gene sequencing of tumours: clinical validity and utility of molecular profiles obtained by next-generation sequencing (NGS) technologies]
2015 Health Information and Quality Authority (HIQA) Health technology assessment of the use of information technology for early warning and clinical handover systems
2015 NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: a systematic review and economic evaluation
2015 Institute of Health Economics (IHE) Post policy implementation review (PPIR) of rapid fetal fibronectin testing for preterm labour in Alberta
2015 Adelaide Health Technology Assessment (AHTA) Endovascular clot retrieval with thrombolysis for ischaemic stroke
2015 Adelaide Health Technology Assessment (AHTA) Leadless Pacemaker
2015 NIHR Horizon Scanning Centre (NIHR HSC) Ibrutinib (Imbruvica) for Waldenström's macroglobulinaemia
2015 NIHR Health Technology Assessment programme Evaluating Long-term Outcomes of NHS Stop Smoking Services (ELONS): a prospective cohort study
2015 NIHR Horizon Scanning Centre (NIHR HSC) Pelareorep (Reolysin) with or without chemotherapy for metastatic malignant melanoma – second line
2014 HAYES, Inc. Duchenne/Becker muscular dystrophy (DMD/BMD)
2014 University of York Preventing falls in hospitals
2014 University of York Preventing pressure ulcers
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Clinical review report. Saxagliptin (Onglyza - Bristol-Myers Squibb/AstraZeneca Canada Inc.) indication: type 2 diabetes mellitus
2014 Scottish Health Technologies Group (SHTG) Transcatheter aortic valve implantation (TAVI) for severe symptomatic aortic stenosis in adults who are not eligible for surgery
2014 Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR) Innovative medical devices for diabetes management - Update of Short report n. 6/2012
2014 Health Information and Quality Authority (HIQA) Health technology assessment (HTA) of public access defibrillation
2014 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Online programs for weight loss
2014 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) HPV OncoTect™ E6, E7 mRNA assay to guide colposcopy referral in cervical cancer screening
2014 Health Quality Ontario (HQO) Parathyroid hormone
2014 HTA Unit, University of Calgary Repetitive transcranial magnetic stimulation for treatment resistant depression
2014 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [How to improve the management of depression? A qualitative approach]
2014 HAYES, Inc. Sex reassignment surgery for the treatment of gender dysphoria
2014 NIHR Health Technology Assessment programme Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation the CASCADE study
2014 HAYES, Inc. Von Hippel-Lindau (VHL) syndrome
2014 Health Quality Ontario (HQO) Arthroscopic debridement of the knee: OHTAC recommendation
2013 Health Quality Ontario (HQO) Transient ischemic attack: where can patients receive optimal care? A rapid review
2013 Andalusian Health Technology Assessment Area (AETSA) [Hyperthermic intraperitoneal chemotherapy. Efficacy and safety in the treatment of ovarian cancer peritoneal carcino matosis]
2013 HAYES, Inc. Use of negative-displacement needleless connectors and rates of catheter-related bloodstream infections
2013 HAYES, Inc. Use of neutral-displacement needleless connectors and rates of catheter-related bloodstream infections
2013 HAYES, Inc. Use of positive-displacement needleless connectors and rates of catheter-related bloodstream infections
2013 The Regional Health Technology Assessment Centre (HTA-centrum) End colostomy - with or without mesh reinforcement
2013 NIHR Health Services and Delivery Research programme An evaluation of foundation doctor training: a mixed-methods study of the impact on workforce well-being and patient care [the Evaluating the Impact of Doctors in Training (EDiT) study]
2013 Health Quality Ontario (HQO) In-home care for optimizing chronic disease management in the community: an evidence-based analysis
2013 Health Quality Ontario (HQO) OHTAC recommendation: deep brain stimulation for treatment-resistant depression